- Lobbying
- knight AND capitol AND consultants
Lobbying Arrangements Results for 'Knight Capitol Consultants'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Retirement Security, Entitlement Reform |
CNO Financial Group
Insurance |
Knight Capitol Consultants | |||
Details Controlled Substances Act provisions relating to the distribution of medication assisted therapies (The Protecting Patient Access to Emergency Medications Act, S. 916/H.R. 304. Adequacy of funding... |
Braeburn Pharmaceuticals, Inc.
|
Knight Capitol Consultants | |||
Details Draft Food and Drug Administration Globalization Act (Rep. Dingell) |
SAP America, Inc.
|
Knight Capitol Consultants | |||
Details Monitor NIOSH proceedings with respect to worker safety and closed-system transfer devices. |
Equashield, LLC
|
Knight Capitol Consultants | |||
Details Coverage for substance abuse and mental health services in legislation to repeal/replace the Affordable Care Act (American Health Care Act HR 1628); adequacy of health care coverage for pain therap... |
Pernix Therapeutics Holdings, LLC
|
Knight Capitol Consultants | |||
Details Potential issues of interest to the life insurance industry, including those affecting retirement savings, in the infrastructure/reconciliation legislation now being considered (Infrastructure, In... |
CNO Financial Group
|
Knight Capitol Consultants | |||
Details Access to medication-assisted therapy for opioid overuse, and the use of telemedicine for provision of services (HR 4531, Support for Patients and Communities Reauthorization/ no Senate number yet ... |
Indivior, Inc.
|
Knight Capitol Consultants | |||
Details Funding for research and clinical trials related to long term studies of COVID-19 at the National Institutes of Health provided in the Consolidated Appropriations Act of 2021 (PL 116-260); Funding ... |
Perspectum
|
Knight Capitol Consultants | |||
Details Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860) Potentia... |
United Natural Products Alliance
|
Knight Capitol Consultants | |||
Details Issues affecting biotechnology firms engaged in developing gene therapies, including: the MVP Act (H.R.2666) authorizing value based payments under the Medicaid program; Proposals to amend the drug... |
ReGenxBio
|
Knight Capitol Consultants | |||
Details Patent Reform Act of 2011 (S. 23) |
PhRMA
|
Knight Capitol Consultants | |||
Details Education about the necessity and safety of vaccines and their role in preventing childhood disease. Issues related to pharmaceutical pricing in general (no specific legislation) |
Sanofi US Services, Inc. (formerly known as "sanofi-aventis U.S. Inc.)
|
Knight Capitol Consultants | |||
Details Implementation and possible change/repeal to provisions related to the Patient Protection and Affordable Care Act (PL 111-178) and the Reconciliation Act (PL 111-152), including implementation of b... |
Genzyme Corporation
|
Knight Capitol Consultants |